wow-inequalities/02-data/intermediate/wos_sample/7e1cf09c1423aaee77c71dc1e09eb3ff-blinder-victoria-s./info.yaml

137 lines
4.4 KiB
YAML

abstract: 'Background: Job loss after a cancer diagnosis can lead to long-term
financial toxicity and its attendant adverse clinical consequences,
including decreased treatment adherence. Among women undergoing
(neo)adjuvant chemotherapy for breast cancer, access to work
accommodations (e.g., sick leave) is associated with higher job
retention after treatment completion. However, low-income and/or
minority women are less likely to have access to work accommodations
and, therefore, are at higher risk of job loss. Given the time and
transportation barriers that low-income working patients commonly face,
it is crucial to develop an intervention that is convenient and easy to
use.
Methods: We designed an intervention to promote job retention during and
after (neo)adjuvant chemotherapy for breast cancer by improving access
to relevant accommodations. Talking to Employers And Medical staff about
Work (TEAMWork) is an English/Spanish mobile application (app) that
provides (1) suggestions for work accommodations tailored to specific
job demands, (2) coaching/strategies for negotiating with an employer,
(3) advice for symptom self-management, and (4) tools to improve
communication with the medical oncology team. This study is a randomized
controlled trial to evaluate the app as a job-retention tool compared to
a control condition that provides the app content in an informational
paper booklet. The primary outcome of the study is work status after
treatment completion. Secondary outcomes include work status 1 and 2
years later, participant self-efficacy to ask an employer for
accommodations, receipt of workplace accommodations during and following
adjuvant therapy, patient self-efficacy to communicate with the oncology
provider, self-reported symptom burden during and following adjuvant
therapy, and cancer treatment adherence.
Discussion: This study will assess the use of mobile technology to
improve vulnerable breast cancer patients'' ability to communicate with
their employers and oncology providers, work during treatment and retain
their jobs in the long term, thereby diminishing the potential
consequences of job loss, including decreased treatment adherence, debt,
and bankruptcy.'
affiliation: 'Blinder, VS (Corresponding Author), Mem Sloan Kettering Canc Ctr MSK,
New York, NY 10021 USA.
Blinder, Victoria S.; Finik, Jackie; Lichtenthal, Wendy G.; Parker, Patricia A.;
Claros, Maria; Suarez, Jennifer; Narang, Bharat; Gany, Francesca, Mem Sloan Kettering
Canc Ctr MSK, New York, NY 10021 USA.
Patil, Sujata, Cleveland Clin, Cleveland, OH 44106 USA.
Makower, Della, Montefiore Med Ctr, New York, NY USA.
Muppidi, Monica, Lincoln Med \& Mental Hlth Ctr, New York, NY USA.'
article-number: '840'
author: Blinder, Victoria S. and Patil, Sujata and Finik, Jackie and Makower, Della
and Muppidi, Monica and Lichtenthal, Wendy G. and Parker, Patricia A. and Claros,
Maria and Suarez, Jennifer and Narang, Bharat and Gany, Francesca
author-email: blinderv@mskcc.org
author_list:
- family: Blinder
given: Victoria S.
- family: Patil
given: Sujata
- family: Finik
given: Jackie
- family: Makower
given: Della
- family: Muppidi
given: Monica
- family: Lichtenthal
given: Wendy G.
- family: Parker
given: Patricia A.
- family: Claros
given: Maria
- family: Suarez
given: Jennifer
- family: Narang
given: Bharat
- family: Gany
given: Francesca
da: '2023-09-28'
doi: 10.1186/s13063-022-06580-7
eissn: 1745-6215
files: []
journal: TRIALS
keywords: 'Employment; Breast cancer; Disparities; Minority; Income; Cancer
survivorship; Financial toxicity; Mobile application'
keywords-plus: 'COMMON TERMINOLOGY CRITERIA; REPORTED OUTCOMES VERSION; LOW-INCOME;
UNDERSERVED WOMEN; WORK; SURVIVORS; IMPACT; VALIDATION; EMPLOYMENT;
PREDICTORS'
language: English
month: OCT 3
number: '1'
number-of-cited-references: '64'
papis_id: 01e75893282a4cb4978036e2e845fce1
ref: Blinder2022interactivemobile
times-cited: '1'
title: 'An interactive mobile application versus an educational booklet to promote
job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized
controlled trial'
type: article
unique-id: WOS:000865247300003
usage-count-last-180-days: '0'
usage-count-since-2013: '3'
volume: '23'
web-of-science-categories: Medicine, Research \& Experimental
year: '2022'